Back
United Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
UTHR
United Therapeutics
Last Price:
$293.18
Seasonality Move:
7.07%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
United Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 296.06 | Buy |
20-day SMA: | 290.93 | Buy |
50-day SMA: | 300.94 | Sell |
200-day SMA: | 335.38 | Sell |
8-day EMA: | 212.95 | Buy |
20-day EMA: | 117.21 | Buy |
50-day EMA: | 53.97 | Buy |
200-day EMA: | 14.52 | Buy |
United Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 73.48 | Buy |
Relative Strength Index (14 RSI): | 51.74 | Buy |
Chaikin Money Flow: | 197494 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (281.03 - 304.31) | Buy |
Bollinger Bands (100): | (285.58 - 326.24) | Sell |
United Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 297.68 while UTHR 8-day simple moving average is 296.06, which is a Buy signal.
-
The stock price of UTHR is 297.68 while United Therapeutics 20-day SMA is 290.93, which makes it a Buy.
-
United Therapeutics 50-day simple moving average is 300.94 while UTHR share price is 297.68, making it a Sell technically.
-
UTHR stock price is 297.68 and United Therapeutics 200-day simple moving average is 335.38, creating a Sell signal.
UTHR Technical Analysis vs Fundamental Analysis
Sell
47
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a SellThe current United Therapeutics [UTHR] share price is $297.68. The Score for UTHR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
United Therapeutics Stock Info
Market Cap:
13.4B
Price in USD:
297.68
Share Volume:
313.9K
United Therapeutics 52-Week Range
52-Week High:
417.82
52-Week Low:
266.98
Sell
47
United Therapeutics (UTHR)
is a Sell
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?The United Therapeutics stock price is 297.68 USD today.
-
Will UTHR stock go up or go down?United Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is overvalued.
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 297.68 while UTHR 8-day exponential moving average is 212.95, which is a Buy signal.
-
The stock price of UTHR is 297.68 while United Therapeutics 20-day EMA is 117.21, which makes it a Buy.
-
United Therapeutics 50-day exponential moving average is 53.97 while UTHR share price is 297.68, making it a Buy technically.
-
UTHR stock price is 297.68 and United Therapeutics 200-day simple moving average is 14.52, creating a Buy signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.88 per share, an increase next quarter of $0.66 per share, an increase this year of $2.59 per share, and an increase next year of $0.97 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is 73.48, suggesting United Therapeutics is a Buy
-
United Therapeutics Relative Strength Index (RSI) is 51.74, which suggest United Therapeutics is overbought
-
The Bollinger Bands (25) for United Therapeutics is (281.03 - 304.31), which suggest United Therapeutics is a Sell
-
The Bollinger Bands (100) for United Therapeutics is (285.58 - 326.24), which suggest United Therapeutics is a Sell
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.